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Abstract: YerA41 is a Myoviridae bacteriophage that was originally isolated due its ability to infect
Yersinia ruckeri bacteria, the causative agent of enteric redmouth disease of salmonid fish. Several
attempts to determine its genomic DNA sequence using traditional and next generation sequencing
technologies failed, indicating that the phage genome is modified in such a way that it is an unsuitable
template for PCR amplification and for conventional sequencing. To determine the YerA41 genome
sequence, we performed RNA-sequencing from phage-infected Y. ruckeri cells at different time points
post-infection. The host-genome specific reads were subtracted and de novo assembly was performed
on the remaining unaligned reads. This resulted in nine phage-specific scaffolds with a total length
of 143 kb that shared only low level and scattered identity to known sequences deposited in DNA
databases. Annotation of the sequences revealed 201 predicted genes, most of which found no
homologs in the databases. Proteome studies identified altogether 63 phage particle-associated
proteins. The RNA-sequencing data were used to characterize the transcriptional control of YerA41
and to investigate its impact on the bacterial gene expression. Overall, our results indicate that
RNA-sequencing can be successfully used to obtain the genomic sequence of non-sequencable phages,
providing simultaneous information about the phage–host interactions during the process of infection.
Keywords: YerA41; bacteriophage; RNA-sequencing; nucleotide modification; genome assembly;
transcriptome; Yersinia ruckeri
1. Introduction
YerA41 is a bacteriophage that was originally isolated due its ability to infect Yersinia ruckeri
bacteria, the causative agent of enteric redmouth disease of salmonid fish [1]. Bacteriophage YerA41
was first described in 1984 as a tailed icosahedral virus that lysed the vast majority of tested Y. ruckeri
serovar I strains, and thus was believed to have a potential value for the diagnosis of redmouth disease.
However, it was found that YerA41 has a relatively broad host range among Enterobacteriacae as it could
infect some strains of other Yersinia species, Escherichia coli, Shigella flexneri, Enterobacter cloacae, Klebsiella
and Erwinia spp. [1]. The YerA41 phage particles are large with heads of about 110 nm in diameter,
10 × 8 nm necks, 250 × 20 nm non-contracted sheaths and 70 nm long tail fibers [2]. Several attempts to
sequence the YerA41 genome using next generation sequencing (Illumina) approaches failed previously.
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Additionally, it was observed that the phage DNA could not be digested by any of the numerous tested
restriction enzymes. These results led to the conclusion that the phage DNA is modified in such a
way that prevents the function of enzymes such as DNAP and DNA-modifying restriction enzymes.
Indeed, preliminary analysis of the nucleosides confirmed the presence of modifications, however,
without revealing their exact nature.
Naturally occurring modifications of the canonical deoxynucleotides can be found in the DNA of
organisms from all domains of life. They may constitute only a small fraction of the bases or even
replace the standard, un-modified base entirely [3]. Collectively, the greatest diversity of modified bases
can be observed among bacteriophages. These modifications include both the types observed among
the bacterial host species, and the more unusual that are not observed among different organisms [4].
A variety of different chemical groups can be attached to the nucleotide, ranging from simple methyl
groups through amino acids, polyamines, monosaccharides to more complexed oligosaccharides. They
do not lead to alterations in the specificity of base pairing, and primarily appear to be a part of the
arms race between the infecting organism and its host. For example, these modifications can provide
additional information needed for the control of gene expression, recognition of self and non-self DNA,
or protection from enzymatic degradation and host defense mechanisms [3,4].
The hypermodified bases observed among phages include 5-hydroxymethylpyrimidines and
their glycosylated derivatives, α-putrescinylated and α-glutamylated thymines, sugar-substituted
5-hydroxypentyl uracil, N6-(1-acetamido)-modified adenine and 7-methylguanine [3,5]. Interestingly,
the hydroxymethyl deoxypyrimidines are produced from free nucleotides by phage-encoded
deoxypyrimidine hydroxymethylases before their incorporation into DNA. This mechanism is different
from the primary base methylations that are commonly catalyzed in situ on DNA. After incorporation,
these hydroxymethylpyrimidines often undergo further modifications introduced by phage-encoded
enzymes such as glycosyl- or acetyl-transferases [3,6,7].
Here, we have used RNA-sequencing to determine the nucleotide sequence of the phage YerA41
genome using its encoded transcripts. This approach allowed us to determine the nucleotide sequence
of the greater part of the phage genome and to characterize its gene expression during infection.
Additionally, our approach provided insight into the interactions between YerA41 and its host
bacterium. Moreover, our results indicated that YerA41 represents a novel, previously unidentified,
group of bacteriophages that at the level of nucleotide sequence shares almost no similarity with those
previously reported.
2. Materials and Methods
2.1. Bacterial Strains and Phage Propagation
Bacteriophage YerA41 was propagated in Y. ruckeri strain RS41 [1] as described previously [8].
Y. ruckeri was grown in lysogeny broth (LB) at room temperature (RT, 22 ◦C). LB agar (LA) plates were
used for all solid cultures and prepared by supplementing LB with 1.5% Bacto agar and 0.4% for soft
agar. Bacteriophage YerA41 was stored at −70 ◦C in tryptic soy broth (TSB) supplemented with 7%
dimethyl sulfoxide (DMSO). The bacterial strains used in this study are listed in Table S1.
2.2. Purification of Phage Particles
The standard method for the production and purification of bacteriophages [9] was used. Briefly,
an overnight culture of host bacteria was diluted 10-fold in TSB in a total volume of 1 L divided into
four 2 L erlenmeyer flasks, 250 mL each, and infected with appropriate number of phage to reach
the multiplicity of infection (MOI) of 1. The infected cultures were incubated at 25 ◦C with vigorous
aeration (250 rpm), until after 6–7 h the bacterial lysis took place. The lysed cultures were treated
with DNase I (1.2 µg/mL; Roche Diagnostic, Mannheim, Germany) and RNase A (1 µg/mL; Sigma
Chemicals, St. Louis, MO, USA) and incubated at RT for 30 min. Solid NaCl was added to a final
concentration of 1 M and lysates were kept on ice for 1 h, and then the solution was centrifuged at
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11,000× g for 10 min at 4 ◦C to remove the precipitated bacterial debris. The phage was recovered
from the supernatant by precipitating with polyethylene glycol (PEG 8000) (10%, w/v; > 60 min; 0 ◦C)
and was resuspended into TM buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgSO4). Alternatively, the
phage was purified from semiconfluent soft-agar plates as described [9]. The phage was further
purified by chloroform extraction and one to three rounds of discontinuous glycerol density gradient
ultracentrifugation at 35,000 rpm at 4 ◦C for 1 h in a Beckman SW41 rotor. After the centrifugations
phages were resuspended in SM buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 8 mM MgSO4, 0.01%
gelatin) containing 8% of sucrose.
2.3. One Step Growth Curve
A mid-exponential-phase culture (10 mL) of RS41 (optical density at 600 nm [OD600] 0.4 to 0.5)
was harvested by centrifugation at 3,000 rpm for 15 min and resuspended in 1 mL of TSB medium.
YerA41 phage was added at MOI of 0.0005 and allowed to adsorb for 2 min at RT. The culture was
then centrifuged, the pelleted bacterial cells were resuspended to 10 mL of TSB, and incubation
was continued at RT. Samples (100 µL) were taken at 10 min intervals. The first set of samples was
immediately diluted and plated on lambda agar plates (per liter of broth: Bacto-agar 15 g; lambda
broth per liter: tryptone 10 g, NaCl 2.5 g) for phage titration. In order to determine the eclipse period
the second set of samples was treated with 1% chloroform before plating to release the intracellular
phage particles [10,11]. The number of plaque forming units (PFU) in the immediately diluted 0 min
time point samples was set to 1 to represent the number of infected cells in the experiment, and the
PFU of all the other samples were normalized against that number. The burst size was then directly
obtained from the normalized value after the rise period.
2.4. Total RNA Extraction
RNA extractions were carried out from three separate infection experiments. In the first experiment,
the RS41 bacteria were grown for 16 h at RT and subsequently diluted 1:20 in fresh LB to a total volume
of 20 mL. When the OD600 of the culture reached 0.7, duplicate 1 mL samples were withdrawn to
represent 0 min uninfected samples, then 9 mL of the culture was infected with 1 mL of phage YerA41
stock (5 × 1010 pfu/mL) to achieve a MOI of ca. 50. Duplicate 1 mL aliquots were withdrawn at 5, 15,
and 30 min post-infection (p.i.). In the second experiment, the RS41 bacteria were grown for 16 h at RT
and subsequently diluted 1:20 in fresh LB to a total volume of 20 mL. When the OD600 of the culture
reached 0.7, 8.5 mL of the culture was infected with 1.5 mL of phage YerA41 stock to achieve a MOI of
10. One mL aliquots were withdrawn at 33, 45, 63, 75 and 92 min p.i. in one replicate each. In the third
experiment, three biological replicates were grown for 16 h at RT and diluted 1:20 in 10 mL. When the
cultures reached OD600 of 0.6, one mL aliquots were withdrawn from each culture, these representing
the uninfected 0 min samples in triplicate. Then, to 5.3 mL of culture 0.7 mL of phage stock was added
to reach a MOI of 50, mixed for 3 min followed by 3 min standing and 3 min centrifugation at 4500× g
at 22 ◦C. The supernatant was replaced with 6 mL fresh medium and triplicate 1 mL samples, one
from each tube, were withdrawn at 15, 30 and 60 min p.i. In all experiments, total RNA was isolated
from the samples using the SV Total RNA Isolation System (Promega, Madison, WI, USA) and the
quality assessment was performed using LabChip (PerkinElmer, Waltham, MA, USA), using the DNA
5K/RNA/CZE chip with HT RNA Reagent Kit.
2.5. RNA Sequencing
The RNA-sequencing and data analysis were performed at the Nu-Omics DNA sequencing
research facility at University of Northumbria. The rRNA was removed using Ribo-ZeroTM rRNA
Removal Kit for Gram-negative Bacteria (Illumina, San Diego, CA, USA). The sequencing library was
prepared using the ScriptSeq-v2 RNA-Seq Library Preparation Kit (Illumina). Paired-end sequencing
was performed on MiSeq (Illumina) with the read length of 150 nucleotides.
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2.6. Transcriptome Assembly
The obtained sequencing reads were quality filtered and aligned against Y. ruckeri PB-H2
chromosome (Acc.no. LN681231.1) and plasmids pYR2 (Acc.no. LN681229.1) and pYR3 (Acc.no.
LN681230.1) using Bowtie2 aligner [12]. The reads that failed to align to these reference sequences were
merged together and assembled using Velvet [13] and SPAdes [14]. The obtained assembled sequences
were blasted against the NCBI nucleotide collection (https://blast.ncbi.nlm.nih.gov/Blast.cgi) and contigs
that showed high sequence identity to Yersinia strains were excluded. The phage genomic scaffolds were
auto-annotated using Rapid Annotation Using Subsystem Technology (RAST, http://rast.nmpdr.org/)
and the obtained annotation was validated manually using the Artemis tool [15]. Presence of suitable
ribosomal binding sites in front of start codons of each predicted gene was confirmed manually. The
tRNA genes were identified using the ARAGORN (http://130.235.46.10/ARAGORN/) and tRNA-SCAN
(http://lowelab.ucsc.edu/tRNAscan-SE/index.html) tools.
2.7. RNA-Sequencing Data Analysis
The quality filtered sequencing reads from different time points were aligned against the obtained
YerA41 assembly scaffolds and against the Y. ruckeri PB-H2 reference sequence using Bowtie2 aligner [12].
The reads aligning over each gene were counted using the HTSeq [16]. The differential gene expression
of bacterial transcriptome was analyzed using the edgeR [17].
2.8. Proteome Analysis
Purified phages were concentrated by centrifugation for 2 h at 4 ◦C at 16,000× g. Prior to the
digestion of proteins to peptides with trypsin, the proteins in the samples were reduced with tris
(2-carboxyethyl)phosphine (TCEP) and alkylated with iodoacetamide. Tryptic peptide digests were
purified using C18 reversed-phase chromatography columns [18] and the mass spectrometry (MS)
analysis was performed on an Orbitrap Elite Electron-Transfer Dissociation (ETD) mass spectrometer
(Thermo Scientific, Waltham, MA, USA), using Xcalibur version 2.2, coupled to an Thermo Scientific
nLC1000 nanoflow High Pressure Liquid Chromatography (HPLC) system. Peak extraction and
subsequent protein identification was achieved using Proteome Discoverer 1.4 software (Thermo
Scientific). Calibrated peak files were searched against the YerA41 and Y. ruckeri PB-H2 chromosome
and plasmid proteins by a SEQUEST search engine. Error tolerances on the precursor and fragment
ions were ±15 ppm and ±0.8 Da, respectively. For peptide identification, a stringent cut-off (0.05 false
discovery rate or 5%) was used. The LC-MS/MS was performed at the Proteomics Unit, Institute of
Biotechnology, University of Helsinki.
2.9. DNA Isolation
Phage DNA was obtained from high-titer phage preparations as described [9] using proteinase K
plus SDS treatment followed by phenol-chloroform extractions and ethanol precipitation.
2.10. Accession Numbers
The RNA sequence data were deposited to the Gene Expression Omnibus (Acc. no GSE146319).
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3. Results
3.1. Characterization of YerA41
The growth curve of YerA41 propagated in Y. ruckeri RS41 is shown in Figure S1. Apparent
eclipse and latent periods of 30 and 40 min, respectively, were followed by a rise period of 20 min,
and the burst size was 138 PFU per infected cell. The host range of YerA41 was studied on bacteria
grown both at RT and at 37 ◦C, as temperature is known to regulate surface structures in the genus
Yersinia [19]. Altogether, 129 strains representing 9 different Yersinia species and 3 other genera were
used (Table 1 and Table S1). All Y. enterocolitica strains except for those of serotype O:8 were resistant to
YerA41. Most tested Y. intermedia and Y. ruckeri strains were sensitive to YerA41 phage at both tested
temperatures. In addition, many Y. kristenseni strains, and the Shigella flexneri strain, were sensitive to
YerA41 (Table 1). Such a broad host range indicates that the phage uses a conserved bacterial surface
structure as a receptor.
Table 1. Host range of bacteriophage YerA41 (numbers of studied strains for each species and serotype
are given in parenthesis). The sensitivity was tested both at RT and at 37 ◦C.
Bacterial Species YerA41 SensitiveSerotypes
YerA41
Sensitive Serotypes
at 37 ◦C
YerA41
Resistant Serotypes or Strains
Yersinia enterocolitica O:8 (5) O:8 (5)
O:1(2),O:1,2,3(1), O:2(2), O:3(2), O:4(1),
O:4,32(2), O:5(3), O:5,27(2), O:6(2),
O:6,30(2), O:6,31(2), O:7,8(8), O:9(2),
O:13,17(1), O:13,7(2), O:13a,13b(2),
O:14(1), O:15(2) O:20(2), O:21(2),
O:25(1), O:25,26(1), O:26,44(1),
O:28,50(1), O:34 (1), O:35,36 (1),
O:35,52(1), O:41(27)43(2), O:41(27)42
K1(1), O:50(2), O:41(27)K1(1),O:41,43(1),
K1 non-typable (2), non-typable(4)
Yersinia
pseudo-tuberculosis - -
O:1(1), O:1a(1), O:1b(1), O:2 (2), O:2a(1),
O:2b(1), O:2c(1), O:3 (2), O:4a (1), O:4b
(1), O:5a (1), O:5b(1), O:6 (1), O:7 (1), O:8
(1), O:9(1),
Yersinia frederikseni - O:16(1),O:35(1) O:48 (1), non-typable (4)
Yersinia intermedia O:16,21(1), O:52,54 (1) O:16,21(1) -
Yersinia kristenseni O:12,25(1), O:16(2),non-typable (1)
O:12.25(1), O:16(2),
non-typable (1) non-typable(1)
Yersinia mollareti - - O:59(20,36,7) (1)
Yersinia pestis - - (2)
Yersinia bercoveri - - O:58,16(1), non-typable(1)
Yersinia ruckeri (2) (2) -
Providencia rettgeri - - (1)
Salmonella typhimurium - - (1)
Shigella flexneri (1) (1) -
3.2. Genome Analysis
The RNA-sequencing reads not aligned to the Y. ruckeri reference genome were de novo assembled;
the obtained unique contigs with no sequence similarity to Yersinia species were scaffolded (Figure 1).
This resulted in nine qualified scaffolds comprising altogether 143,296 bp (Table 2, Figure 2). The overall
GC ratio of the YerA41 genome was 32.3%. Importantly, the scaffolds did not present any significant
overall identity to nucleotide sequences stored in databases.
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Figure 1. Workflow of the RNA-seq approach. Freshly diluted Y. ruckeri RS41 bacteria were grown
until OD600 = 0.6 and then infected with phage YerA41 at MOI equal to 10 or 50. The culture was
washed with LB to remove the unbound phage particles, and thus prevent re-infection of bacterial
cells at later stages of the experiment. Samples for RNA isolation were taken at different time points
p.i. (0, 5, 15, 33, 45, 63, 75, 92 min). After the removal of bacterial rRNA, the prepared libraries were
sequenced. The obtained sequencing reads were quality filtered and aligned against Y. ruckeri PBH2
chromosome (Acc.no. LN681231.1) and plasmids pYR2 (Acc.no. LN681229.1) and pYR3 (Acc.no.
LN681230.1). The reads that failed to align to these reference sequences were merged together and
assembled using Velvet [13] and SPAdes [14]. The obtained assembled sequences were blasted against
the NCBI nucleotide collection and contigs showing high identity rates with Yersinia strains were
excluded. The phage genomic scaffolds were auto-annotated using Rapid Annotation Using Subsystem
Technology (RAST) [20]. Presence of suitable ribosomal binding sites in front of each predicted start
codon was confirmed. Figure was created using BioRender (https://app.biorender.com).
A total of 201 putative genes were detected by RAST analysis and manual annotation. Predicted
functions could be assigned to 60 of the 201 gene products, the others showed no significant
similarity to any protein sequences in the databases (Table 3 and Table S2). The predicted
YerA41 gene products showed similarity to DNA polymerases (Gp061, Gp097, Gp137, Gp0195)
and RNA polymerase β-, β’- and other subunits (Gp019, Gp054, Gp055, Gp056, Gp162), helicases
(Gp143, Gp145, Gp193), topoisomerases (Gp135, Gp136, Gp190), and a DNA ligase (Gp199).
In addition, the predicted genes encode for enzymes involved in nucleoside metabolism, including
5′-deoxynucleotidase (Gp060), dCTP deaminase (Gp114), dUTP diphosphatase (Gp141), thymidylate
synthetase (Gp127), ribonucleoside-diphosphate reductase (Gp110), ribonucleotide reductase (Gp109),
and several endo- and exo-nucleases (Gp126, Gp149, Gp167, Gp179, Gp180, Gp189). The other
gene products with recognizable function encoded different phage structural proteins. Three tRNA
genes encoding tRNA-Arg, tRNA-Met, and tRNA-Leu, were identified by both ARAGORN and
tRNA-SCAN, all located in a module on the scaffold_3. Finally, the gene g064-g070 products
showed similarity to UDP-GlcNAc 2-epimerase, SDR family oxidoreductases, polysaccharide
deacetylase, 2-C-methyl-D-erythritol-4-phosphate cytidylyltransferase, and glycerophosphodiester
phosphodiesterase, suggesting them roles in biosynthesis of sugar-modified nucleotides.
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Figure 2. Gene organization of the nine scaffolds of the phage YerA41 genome. The scaffolds are
organized based on size. The gene colors indicate predicted functions of their products: Green,
hypothetical proteins; Blue, RNA polymerase subunits; Red, DNA polymerase-like proteins; Brown,
phage particle associated (structural) proteins. The figure was generated using Geneious 10.2.6
(www.geneious.com).
Table 2. The assembled scaffolds of YerA41 genome. The numbering of the scaffolds is based on their
length and does not reflect their actual position in the phage genome.
ID Size [bp] GC%
scaffold_1 42 987 34.5
scaffold_2 27 377 31.6
scaffold_3 26 591 31.7
scaffold_4 15 134 32.0
scaffold_5 11 502 32.8
scaffold_6 8 240 29.6
scaffold_7 5 287 28.9
scaffold_8 3 672 29.6
scaffold_9 2 506 29.6
TOTAL/Average: 143 296 32.3
3.3. Proteomic Analysis of the Phage Structural Proteins
To determine the phage particle associated and structural proteins, a proteomic analysis of
the purified phage particles using LC-MS/MS was carried out. The structural proteins were
identified through the comparative analysis of the obtained tryptic peptide sequence patterns and the
sequence-based in silico determined tryptic peptide sequences of phage proteins. Altogether, 63 phage
proteins were reliably identified in the LC-MS/MS analysis (Table S2). The analysis revealed among the
identified proteins structural proteins such as major capsid, tail sheath, baseplate wedge, tail fiber, and
tail fiber assembly proteins. In addition, several DNA- or RNA modifying enzymes, such as DNA
polymerases, helicases, recombinases, topoisomerases, endo- and exonucleases, and RNA polymerase
subunits and a sigma factor were phage particle associated proteins (PPAPs, Table S2). These are likely
to be injected into the bacteria along with the genomic DNA to take over the host metabolism as soon
as possible after infection (Table S2).
3.4. Temporal Expression of Phage Genes
The heatmap of YerA41 genes expressed at different time points revealed evident temporal gene
expression (Figure 3). The mean values of expression of early (5–15 min p.i.), middle (33–45 min), and
late (63–92 min) were calculated and compared between each other. A gene was assigned to certain
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class based on the post infection time when its expression peaked (Table 3 and Table S2). In total 47
genes (23.4% of phage putative genes) had their highest expression in the first min post infection.
The function of the majority of the gene products remained unknown, yet six of the gene products
were predicted to be involved in nucleic acid processing. Interestingly, the genes of the early phase
were scattered across several scaffolds. The heatmap (Figure 3) shows that the YerA41 gene expression
progresses rapidly and indistinctly to the middle phase. This phase was characterized by the expression
of 101 (50.2%) genes, including numerous genes presumably involved in nucleic acid metabolism.
During the latest state of infection, 51 (25.4%) genes were induced. According to the in silico analysis,
the majority of these genes encode for the structural proteins of phage particles. The remaining two
putative genes (the g200 and g201 genes) showed minimal expression with no changes throughout the
course of infection; thus, it is highly probable that they constitute bioinformatics artifacts.
Table 3. Temporal expression profiles of the gene products of phage YerA41 having predicted functions.
The full list of all gene products, including the hypothetical proteins of unknown function, is presented
in Supplementary Table S2. The LC-MS/MS-identified PPAPs are marked with asterisk.
Temporal Expression Gene ID Scaffold Putative Functions of Gene Products Based onDatabase Similarity
Early g054 2 DNA directed RNA polymerase, subunit*
g055 2 DNA-directed RNA polymerase, subunit*
g056 2 DNA-directed RNA polymerase*
g078 2 Lytic transglycosylase
g097 3 DNA polymerase III, subunit
g116 3 RNA 2’-phosphotransferase
g126 3 Endonuclease-like protein
g135 4 DNA topoisomerase*
g161 5 Tail fiber protein
g162 5 DNA directed RNA polymerase, subunit / PutativeDNA helicase
g189 7 Endonuclease-like protein
g190 7 DNA topoisomerase*
g193 7 Helicase*
g195 8 DNA polymerase
g199 9 DNA ligase*
Middle g060 2 5’-deoxynucleotidase
g061 2 DNA polymerase*
g064 2 UDP-GlcNAc 2-epimerase
g065 2 Oxidoreductase
g066 2 SDR family oxidoreductase
g067 2 Polysaccharide deacetylase
g068 2 2-C-methyl-D-erythritol 4-phosphatecytidylyltransferase (EC 2.7.7.60)
g070 2 Glycerophosphodiester phosphodiesterase
g109 3 Ribonucleotide reductase
g110 3 Ribonucleoside-diphosphate reductase subunit alpha*
g112 3 Ribosomal protein modification protein*
g114 3 dCTP deaminase
g127 3 Thymidylate synthetase
g133 4 Transglycosylase
g136 4 DNA topoisomerase*
g137 4 DNA polymerase III, subunit*
g140 4 Structural protein
g141 4 dUTP diphosphatase*
g143 4 ATP-dependent DNA helicase*
g145 4 Replicative helicase
g149 4 Exodeoxyribonuclease*
g167 5 Endonuclease*
g174 5 Phage baseplate assembly protein
g179 6 Exonuclease
g180 6 Exonuclease*
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Table 3. Cont.
Temporal Expression Gene ID Scaffold Putative Functions of Gene Products Based onDatabase Similarity
Late g007 1 DNA packaging terminase*
g012 1 Prohead core protein protease*
g014 1 Capsid protein*
g016 1 Sugar binding protein*
g019 1 RNA polymerase sigma factor*
g024 1 Phage tail sheath protein*
g025 1 Tail protein
g028 1 Tail family protein*
g031 1 Tail protein
g032 1 Tail protein
g034 1 Tail-associated lysozyme
g035 1 Tail-associated lysozyme
g037 1 Baseplate wedge protein*
g040 1 Capsid protein
g041 1 Virion structural protein
g042 1 Baseplate wedge protein*
g043 1 Tail fiber protein*
g044 1 Phage tail fiber assembly protein*
g045 1 Tail fiber protein*
g049 1 Endolysin*
Figure 3. Heatmap of YerA41 genes expressed at different time points post infection. Gene expression
values were normalized to the highest expression to show the timing of expression; therefore, the
intensity of color on the heatmap reflects the difference of expression of one gene at different time
points, yet not the difference of expression between different genes.
3.5. Bacterial Response to Lytic Infection
It is crucial to get insight into different phases of phage infection in order to understand the
bacterial host response. Based on the one-step growth curve and the results of short time interval
RNA-sequencing, three different time points: 15, 30, and 60 min p.i. were chosen as the representative
timepoints for early, middle, and late stages of infection. Analysis of the RNA-sequencing data from
three independent biological replicates revealed that Y. ruckeri differentially regulated the expression
of 167 genes during the early stage of infection (15 min p.i.). Among the differentially expressed
genes of the bacterial host (4.6%), 38% of the genes showed upregulation, and the remaining 62%
showed downregulation (Table 4). Most of the upregulated genes encoded products implicated in
the protection of bacterial cells from oxidative damage. These included genes encoding catalase
(CSF007_12285), thioredoxin (CSF007_14055), glutaredoxin (CSF007_6685), peroxiredoxin family
protein (CSF007_17480), glutathione reductase (CSF007_0665), and thioredoxin reductase (CSF007_6870).
Additionally, RNA-sequencing showed the induction of genes involved in glycolysis, namely the
genes encoding dihydrolipoamide dehydrogenase (CSF007_17485), glucose-6-phosphate isomerase
(CSF007_16360), and pyruvate kinase (CSF007_9590), as well as three genes involved in the biosynthesis
of siderophores (CSF007_15200, CSF007_15205, CSF007_15210). Among the host bacterium genes
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presenting the strongest upregulation p.i. was dps (CSF007_6300), which encodes a non-specific
DNA-binding protein involved in DNA protection during exposure to severe environmental insult.
An increase in expression was also observed for host bacterium genes involved in the biosynthesis of
antibacterial agents like polymyxin and enterobactin (CSF007_15260, CSF007_15255, CSF007_15265).
In contrast, the bacteria downregulated genes that are involved in the metabolism of different
carbohydrates, as well as several genes encoding the succinate dehydrogenase complex (CSF007_5810,
CSF007_5800, CSF007_5795, CSF007_5805).
Table 4. Transcriptional response of Y. ruckeri to infection with YerA41. The list of bacterial genes
showing significant (p-value < 0.001) differential expression at both 15 min and 30 min time points
compared to non-infected bacteria. The lists of genes differentially expressed at different time points
(15, 30 and 60 min p.i.) are presented in Supplementary Table S3. LogFC; log-ratio of a transcript’s
expression values in two different conditions. FDR; False Discovery Rate.
Gene ID Function
15 min 30 min
logFC FDR logFC FDR
CSF007_17485 Dihydrolipoamide
dehydrogenase
7.07 1.97 × 10−146 1.28 2.16 × 10−07
CSF007_17480 Peroxiredoxin family
protein/glutaredoxin
6.95 4.94 × 10−128 1.12 7.36 × 10−05
CSF007_6300 Non-specific DNA-binding
protein Dps / Iron-binding
ferritin-like antioxidant protein /
Ferroxidase
4.39 4.13 × 10−66 1.90 5.48 × 10−11
CSF007_12285 Catalase 4.10 3.26 × 10−59 1.54 9.40 × 10−09
CSF007_9590 Pyruvate kinase 1.95 7.27 × 10−15 2.11 9.00 × 10−13
CSF007_11760 Putrescine importer 1.43 1.44 × 10−07 1.71 4.96 × 10−05
CSF007_5840 Cytochrome d ubiquinol oxidase
subunit I
1.21 1.89 × 10−06 1.49 0.00011
CSF007_5845 Cytochrome d ubiquinol oxidase
subunit II
1.14 1.98 × 10−06 1.48 2.78 × 10−05
CSF007_13405 Inosine-5-monophosphate
dehydrogenase
0.91 0.00034 1.19 0.00017
CSF007_12920 hypothetical protein 0.88 0.00014 1.11 0.00015
CSF007_5505 hypothetical protein −0.78 1.77 × 10−05 −1.18 1.44 × 10−05
CSF007_14715 Glycine cleavage system H protein −0.81 0.00044 −1.88 3.38 × 10−07
CSF007_9025 Alkyl sulfatase −0.93 2.94 × 10−06 −1.32 1.03 × 10−05
CSF007_13885 D-ribulokinase −0.94 6.94 × 10−07 −2.04 9.33 × 10−14
CSF007_13880 Phosphosugar isomerase/binding
protein
−1.01 2.19 × 10−06 −1.98 6.52 × 10−09
CSF007_1760 Aspartate ammonia-lyase −1.02 6.88 × 10−05 −1.98 3.86 × 10−12
CSF007_0675 Oligopeptidase A −1.03 0.00043 −1.29 0.00043
CSF007_9680 Hemin transport protein HmuS −1.06 1.77 × 10−05 −1.38 0.00097
CSF007_17975 Glutamine synthetase type I −1.09 0.00014 1.92 4.07 × 10−05
CSF007_14720 Aminomethyltransferase (glycine
cleavage system T protein)
−1.11 3.59 × 10−09 −1.69 7.18 × 10−10
CSF007_11035 Transcriptional repressor of PutA
and PutP / Proline dehydrogenase
(Proline oxidase) /
Delta-1-pyrroline-5-carboxylate
dehydrogenase
−1.12 9.24 × 10−06 −2.14 5.30 × 10−14
CSF007_13080 NADP-dependent malic enzyme −1.12 9.98 × 10−08 −1.68 2.82 × 10−09
CSF007_6400 Galactose/methyl galactoside ABC
transport system ATP-binding
protein MglA
−1.13 1.92 × 10−07 −1.72 6.99 × 10−09
CSF007_0690 Universal stress protein A −1.20 1.55 × 10−07 −1.56 5.98 × 10−06
CSF007_0605 Aerobic C4-dicarboxylate
transporter for fumarate/L-malate/
D-malate/succunate
−1.23 1.07 × 10−09 −1.09 0.00046
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Gene ID Function
15 min 30 min
logFC FDR logFC FDR
CSF007_1210 Cyclic AMP receptor protein −1.32 5.98 × 10−08 −1.42 1.30 × 10−05
CSF007_0245 16 kDa heat shock protein A −1.37 0.00033 −1.80 6.55 × 10−06
CSF007_5820 Dihydrolipoamide
succinyltransferase component
(E2) of 2-oxoglutarate
dehydrogenase complex
−1.41 7.97 × 10−08 −2.87 1.10 × 10−12
CSF007_18075 Ribose ABC transport system
periplasmic ribose-binding
protein RbsB
−1.41 1.96 × 10−11 −1.57 8.42 × 10−07
CSF007_16000 hypothetical protein −1.42 2.65 × 10−06 −1.99 6.12 × 10−06
CSF007_11865 Mannonate dehydratase −1.46 8.78 × 10−10 −2.13 6.04 × 10−12
CSF007_13895 Ribose ABC transport system
permease protein RbsC
−1.48 1.29 × 10−12 −2.07 7.16 × 10−12
CSF007_0935 Transcriptional activator of
maltose regulon MalT
−1.49 7.07 × 10−14 −1.48 8.42 × 10−07
CSF007_16315 Maltose operon periplasmic
protein MalM
−1.51 6.85 × 10-06 −2.03 0.00043
CSF007_18085 Ribose ABC transport system
ATP-binding protein RbsA
−1.51 7.72 × 10−10 −1.85 2.56 × 10−06
CSF007_9675 TonB-dependent hemin
ferrichrome receptor
−1.55 9.46 × 10−16 −1.13 0.00018
CSF007_5825 Succinyl-CoA ligase
[ADP-forming] beta chain
−1.60 7.19 × 10−08 −2.86 5.80 × 10−10
CSF007_5830 Succinyl-CoA ligase
[ADP-forming] alpha chain
−1.63 1.56 × 10−09 −3.01 4.78 × 10−14
CSF007_18090 Ribose ABC transport system high
affinity permease RbsD
−1.66 1.10 × 10−11 −2.16 4.82 × 10−08
CSF007_16340 Maltose/maltodextrin ABC
transporter substrate binding
periplasmic protein MalE
−1.68 5.91 × 10−08 −2.03 1.45 × 10−06
CSF007_3355 Aconitate hydratase 2 −1.69 3.40 × 10−12 −1.66 1.56 × 10−06
CSF007_5815 2-oxoglutarate dehydrogenase E1
component
−1.80 2.19 × 10−13 −2.96 3.74 × 10−18
CSF007_9550 Putative transport protein −1.80 4.34 × 10−12 −1.51 2.19 × 10−06
CSF007_16325 Maltose/maltodextrin transport
ATP-binding protein MalK
−1.81 6.80 × 10−06 −2.93 3.65 × 10−08
CSF007_9650 Phosphoenolpyruvate synthase −1.82 6.56 × 10−15 −2.54 1.16 × 10−09
CSF007_11875 D-mannonate oxidoreductase −1.87 3.62 × 10−13 −2.57 4.08 × 10−14
CSF007_12965 Sialic acid transporter (permease)
NanT
−1.92 2.90 × 10−12 −2.72 4.08 × 10−14
CSF007_13900 Ribose/xylose/arabinose/galactoside
ABC-type transport system
ATP-binding protein
−2.08 2.79 × 10−28 −2.06 7.97 × 10−05
CSF007_6395 Galactose/methyl galactoside ABC
transport system
galactose-binding periplasmic
protein MglB
−2.08 2.72 × 10−14 −2.79 1.40 × 10−17
CSF007_11455 hypothetical protein −2.12 8.23 × 10−28 −1.57 4.48 × 10−05
CSF007_0865 Gluconokinase −2.12 9.37 × 10−17 −1.80 7.28 × 10−06
CSF007_12460 membrane protein −2.21 3.34 × 10−18 −2.35 7.75 × 10−09
CSF007_15720 Hexuronate transporter −2.38 7.15 × 10−28 −2.40 1.25 × 10−10
CSF007_17650 Glycerol uptake facilitator protein −2.39 1.55 × 10−28 −2.08 5.48 × 10−11
CSF007_16005 Trehalose-6-phosphate hydrolase −2.46 3.37 × 10−14 −3.86 3.31 × 10−24
CSF007_5810 Succinate dehydrogenase
iron-sulfur protein
−2.47 1.33 × 10−16 −3.06 6.67 × 10−15
CSF007_13910 Ribose/xylose/arabinose/galactoside
ABC-type transport system
periplasmic sugar binding protein
−2.48 1.26 × 10−19 −3.70 1.55 × 10−33
CSF007_5800 Succinate dehydrogenase
hydrophobic membrane anchor
protein
−2.49 4.39 × 10−19 −2.64 1.15 × 10−10
CSF007_17655 Glycerol kinase −2.56 1.20 × 10−19 −3.31 2.81 × 10−15
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Gene ID Function
15 min 30 min
logFC FDR logFC FDR
CSF007_5795 Succinate dehydrogenase
cytochrome b-556 subunit
−2.64 4.76 × 10−26 −2.04 9.68 × 10−13
CSF007_15715 hypothetical protein −2.64 2.61 × 10−10 −3.74 1.21 × 10−17
CSF007_5805 Succinate dehydrogenase
flavoprotein subunit
−2.65 2.01 × 10−22 −3.18 3.94 × 10−18
CSF007_12450 Ascorbate-specific PTS system,
EIIA component
−3.07 6.74 × 10−23 −3.17 6.76 × 10−10
CSF007_12455 Putative sugar
phosphotransferase component
II B
−3.21 1.62 × 10−22 −3.52 1.76 × 10−09
CSF007_5790 Citrate synthase −3.23 8.51 × 10−22 −3.12 8.36 × 10−10
CSF007_13905 hypothetical protein −3.28 2.14 × 10−13 −5.24 6.87 × 10−10
CSF007_16010 PTS system, trehalose-specific IIB
component-PTS system
−3.39 3.53 × 10−41 −3.85 1.29 × 10−27
At the mid time point, 30 min p.i., altogether 98 host bacterium genes presented significantly
differential pattern of expression. Of the genes, 78% were significantly downregulated in response to
the ongoing YerA41 infection. Further decrease in the expression of host bacterium genes encoding
for succinate dehydrogenase complex (CSF007_5805, CSF007_5810, CSF007_5830, CSF007_5800,
CSF007_5825, CSF007_5795) and those involved in carbohydrate metabolism and transport of sugars
was observed when compared to the 15 min (early) time point (Table 4). A substantially smaller
fraction (22%) of host bacterium genes were upregulated when compared to uninfected bacteria. That
includes increase in expression of genes encoding cytochrome d ubiquinol oxidase subunits I and II
(CSF007_5840 and CSF007_5845) and DNA-binding protein Fis (CSF007_16180)—a prominent factor
implicated in bacterial gene regulation. Yet, the strongest overexpression was observed for the cold
shock protein CspG (CSF007_10385). Similar to the initial phase of infection, bacteria responded
by positive induction of expression of genes encoding the non-specific DNA-binding protein Dps,
and catalase.
Interestingly, during the late phase, (60 min p.i.), only 15 host bacterium genes showed significantly
different expression level when compared to the uninfected bacteria. All but one (phosphoenolpyruvate
synthase, CSF007_9650) showed downregulation of expression. The strongest decrease in expression
was observed for genes implicated in the metabolism of fructose, including the fructose-specific
phosphocarrier protein HPr, fructose-specific PTS system component and 1-phosphofructokinase
(CSF007_11820, CSF007_11810, CSF007_11815). Moreover, during this phase, bacteria downregulated
the expression of genes encoding for factors involved in ribonucleotide reduction, such as protein
NrdH and reductases of class Ib (CSF007_13980, CSF007_13985, CSF007_13990).
4. Discussion
In this study, we show that a transcriptomic approach can be used to obtain the genomic sequence
of infectious organisms that cannot be sequenced using traditional DNA based sequencing approaches
as they may possess hypermodified deoxyribonucleotides. The major advantage of the method is
that it allows us to obtain the sequence of the viral transcriptome and the insight into the phage-host
interaction simultaneously during the infection process. Since the phage genomes are characteristically
compactly packed with minimal non-coding regions, their transcriptomes constitute the vast majority
of genomic sequences, leaving very little of the unresolved genomic sequence.
We performed our RNA-sequencing study on bacterial cells infected at a relatively high MOI
(MOI = 50) compared to other phage-host analyses [21,22]. At this MOI value, nearly all the bacterial
cells in the culture are infected by the phage; therefore, the pattern of gene expression displayed in
this study should reflect the bacterial response to lytic phage infection. One interesting phenomenon
observed in this study was that the number of differentially expressed bacterial host genes decreased
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throughout the course of infection. We believe that it is caused by some degree of degradation of host
transcripts, in combination with differences in ratio between the infected and uninfected bacteria in
later phases of infection. In this situation, the degraded RNA transcripts from the infected cells would
be lost.
Based upon active gene expression during infection, the YerA41 genome contains >201 putative
genes; however, of these, only 60 could be assigned a predictive function. The remaining gene products
exibited very limited amino acid sequence similarity to other proteins deposited in the databases,
further illustrating the novelty of the YerA41 bacteriophage. Among the known gene products, there
were several DNAP, RNAP β- and β’-subunits, topoisomerases, DNA ligase, helicases, as well as endo-
and exonucleases. The functional analysis of these genes also revealed the presence of a putative
endolysin (g49). Due to the ability to lyse bacterial cell walls, endolysins are considered to be of special
interest as potential novel antimicrobials [23,24]. A very interesting group of genes were identified
from scaffold 2, where the gene g064-g070 products showed similarities sugar biosynthesis related
enzymes, suggesting that they might play a role in biosynthesis of sugar-modified nucleotides.
The obtained genomic sequence indicates that YerA41 is a member of a novel, previously
unidentified, group of bacteriophages. At the nucleotide level it shares no significant similarity with
genomic sequences of any known organisms deposited in the databases. Conversely, the in silico
analysis revealed the presence of multiple unique proteins that are predicted to be involved in nucleic
acid processing and metabolism. Taking this into consideration, it is logical that it is equipped with its
own machinery for transcription and amplification of the genetic information. At the moment, the
exact nature of the nucleotide modification present in the genome of YerA41 is still unknown, but the
research tackling this question is ongoing.
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